Similis Bio And Blau To Co-Develop Four Biosimilars For The Americas

The Drugs Have An Estimated Global Market Value Of $42bn

 
• By Rosalind Rei

JSR Life Science’s new business unit embarks on its first partnership with publicly listed Brazilian pharmaceutical.

Glassy Globe, Showing The Americas, Set Against A Pale Gradient Background
The biosimilars will initially launch in North and South America • Source: Shutterstock

More from Deals

More from Business